Pressure Grows on U.S. Companies to Share Covid Vaccine Technology

Moderna accepted $2.5 billion in taxpayer money to develop its Covid-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company to license its technology.Moderna accepted $2.5 billion in taxpayer money to develop its Covid-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company to license its technology.Vaccination and Immunization, Public-Private Sector Cooperation, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Factories and Manufacturing, Intellectual Property, Moderna Inc, Pfizer Inc, Biden, Joseph R Jr, AfricaRead More

Leave a Reply

Your email address will not be published.